课题基金 / 基金详情

Cytokine gene expression in atopic dermatits

Cytokine gene expression in atopic dermatits
特应性皮炎中细胞因子基因的表达
批准号:
06670870
负责人:
TANAKA Yoichi
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

TANAKA Yoichi的其他基金

相似基金

相关文献

中文摘要
翻译
到目前为止,一些研究结果表明,特应性皮炎(AD)患者中以2型辅助T细胞(Th2)为主。另一方面,最近通过逆转录聚合酶链式反应(RT-PCR)证实了干扰素-γ(干扰素-γ)信使RNA(MRNA)在AD皮损中的优势表达。为了解决这个有争议的问题,我们用原位杂交(ISH)和免疫组织化学方法研究了5例AD患者皮损中IL-4和干扰素-γ的转录和翻译。在mRNA和蛋白水平观察到IL-4和干扰素-γ的共同表达。干扰素-γmRNA阳性细胞数(14.0±6.7)显著高于IL-4mRNA阳性细胞数(2.4±1.1)(p=0.04)。干扰素-γ(6.3;+-gt;2.8)的阳性染色细胞数也明显高于IL-4(1.8-1.2)(p=0.04)。IL-4mRNA阳性细胞数与AD病情严重程度呈正相关(r=0.76,p=0.13),提示IL-4在AD发病机制中起重要作用。
英文摘要
To date, a number of findings suggesting a predominance of type 2 helper T cell (Th2) have been reported in atopic dermatitis (AD). On the other hand, a predominance of interferon-gamma (IFN-gamma) messenger RNA (mRNA) expression was recently demonstrated by reverse transcription polymerase chain reaction (RT-PCR) in the lesions of AD.To address the controversial issue, we investigated both transcription and translation of interleukin-4 (IL-4) and IFN-gamma in the lesions of five AD patients by in situ hybridization (ISH) and immunostaining. In mRNA and protein level, coexpression of IL-4 and IFN-gamma was observed. The number of IFN-gamma mRNA-positive cells (14.0<plus-minus>6.7) was significantly higher than that of IL-4 mRNA-positive cells (2.4<plus-minus>1.1) (p=0.04). The number of positive staining cells of IFN-gamma (6.3<plus-minus>2.8) were also significantly higher than that of IL-4 (1.8<plus-minus>1.2) (p=0.04). However, the number of IL-4 mRNA-positive cells tended to correlate with the AD severity (r=0.76, p=0.13), suggesting an important role of IL-4 in the pathogenesi
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Tanaka Y,Zhang HM,Bae SJ,Hakugawa J,Takenaka M,Anan S and Katayama I: "Coexpression of interleukin-4 and interferon-gamma messenger RNA in lesional skin of atopic dermatitis" (in preparation).
Tanaka Y、Zhang HM、Bae SJ、Hakukawa J、Takenaka M、Anan S 和 Katayama I:“特应性皮炎病变皮肤中白细胞介素 4 和干扰素 γ 信使 RNA 的共表达”(准备中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka Y et al: "Coexpression of interleukin-4 and interferon-γ messenger RNA in lesional skin of atopic dermatitis" (in preparation).
Tanaka Y 等人:“特应性皮炎病变皮肤中白细胞介素 4 和干扰素 γ 信使 RNA 的共表达”(准备中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of the Active Learning Assessment e-Portfolio System to Make Proactive Learning a Habit
  • 批准号:
    16K01093
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2016
  • 负责人:
    TANAKA Yoichi
  • 依托单位:
The Design of Learning Environment which uses an External Community for Authentic Learning
  • 批准号:
    23501189
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    TANAKA Yoichi
  • 依托单位:
Pharmacogenetics of 6-mercaptopurine maintenance therapy for acutelymphoblastic leukemia in Japanese
  • 批准号:
    22790170
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.83万
  • 财政年份:
    2010
  • 负责人:
    TANAKA Yoichi
  • 依托单位:
Anapylactic reaction and cytokine expression in gut form mice oral challnged with ovalbumin
  • 批准号:
    08670974
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.41万
  • 财政年份:
    1996
  • 负责人:
    TANAKA Yoichi
  • 依托单位:
国内基金
海外基金
肠道菌群代谢产物SCFA调控Th1/Th2失衡在儿童过敏性鼻炎中的作用及益生菌靶向干预研究
  • 批准号:
    2026JJ82542
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢骏
  • 依托单位:
基于“金虚宜敛”理论探讨过敏煎经“共生菌-肠肺轴-Th1/Th2免疫失衡”途径防治哮喘的药效机制
  • 批准号:
    JCZRLH202600644
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于肠-肺轴探讨呼吸道菌群-FXR-NLRP3信号通路对儿童支原体肺炎 Th1/Th2免疫失衡的调控机制
  • 批准号:
    2026JJ82012
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周莲花
  • 依托单位:
百日咳影响Th1/Th2失衡加重儿童哮喘气道炎症反应机制研究